Institute of Cardiology

Slides:



Advertisements
Similar presentations
MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.
Advertisements

Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial O.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just.
Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
An International Randomized Trial of Early Versus Delayed Invasive Strategies in Patients with Non-ST Segment Elevation Acute Coronary Syndromes TIMACS.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
PPAR  activation Clinical evidence. Evolution of clinical evidence supporting PPAR  activation and beyond Surrogate outcomes studies Large.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
The Influence of Proton Pump Inhibitors on Clinical Outcomes After Successful Percutaneous Coronary Intervention Kishore J. Harjai, MD, FACC Chetan Shenoy,
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Impact of In-Hospital Revascularization on Survival in Patients With Non–ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure Philippe Gabriel.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Invasive Versus Conservative Strategy in Patients Aged 80 years or Older with NSTEMI or Unstable Angina(After Eighty study) Nicolai Tegn, Michael Abdelnoor,
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Benefit of Early Invasive Therapy in Acute Coronary.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.
PJ Devereaux, MD, PhD McMaster University
Jose M. de la Torre Hernández … in behalf of the 3D investigators
Associate Professor, Honorary Consultant Cardiologist
A Clinical profile of patients enrolled in the Pakistan ACS registry
Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital
Risk Stratification of Chest Pain: Best Practices
Should we care about post-procedural troponin in elective coronary stenting ?   Michel Zeitouni, Johanne Silvain*, Mathieu Kerneis, Olivier Barthelemy,
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
POSTER 3 7:24 – 7:31 Impact of an Invasive Strategy on In-Hospital Outcomes in Nonagenarians with Acute Coronary Syndrome:
Impact of Percutaneous Coronary Angioplasty and Extra-Corporal Life Support on Survival of Patients with Out of Hospital Cardiac Arrest.   Morgan Benais,
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Andre Lamy on behalf of the COMPASS Investigators
Is There a Role for Aspiration in STEMI?
On behalf of J. Belardi, M. Leon, L. Mauri,
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
CHD-related catheterization
ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.
Terms of Use. Terms of Use.
European Heart Association Journal 2007 April
American College of Cardiology Presented by Dr. Stephan Windecker
The Management of ACS “Updated Perspectives and Goals” Rafid F. Al-Aqeedi FIBMS ( Med ), MRCP (London), DM ( Int.Card.), FACC, FESC Consultant Interventional.
Fewer PCIs After Public Reporting Changes in NY
Date: Presenter: Ryan Chen
Invasive versus conservative treatment in unstable coronary syndromes
Kay Lee Park, MD, Robert J. Goldberg, PhD, Frederick A
Preventive Angioplasty in Myocardial Infarction Trial
The European Society of Cardiology Presented by RJ De Winter
American College of Cardiology Presented by Dr. Michel R. Le May
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Global Registry of Acute Coronary Events: GRACE
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Maintenance of Long-Term Clinical Benefit with
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Atlantic Cardiovascular Patient Outcomes Research Team
Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome (CABG-ACS) trial. Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome.
NOBLE Trial design: Patients with unprotected left main disease were randomized to either PCI with a drug-eluting stent (DES) (88% biolimus) or CABG. They.
Presentation transcript:

Institute of Cardiology G. Montalescot Institute of Cardiology Paris - France Unprotected Left Main Revascularization in Patients With Acute Coronary Syndromes G Montalescot, D Brieger, KA Eagle, FA Anderson, G FitzGerald, MS Lee, PG Steg, A Avezum, SG Goodman, JM Gore for the GRACE Investigators

Background Limited information on revascularization for unprotected left main coronary disease (ULMCD) :  a few randomized studies performed in stable patients  a limited number of small observational studies We explored the treatment strategies applied to ULMCD in: Unstable patients (ACS) Emergency (e.g. STEMI) Serious cases (e.g. shock, cardiac arrest) GRACE registry: Data from 106 hospitals in 14 countries in North and South America, Europe, Australia, and New Zealand, between 2000 and 2007 (www.outcomes.org/grace) in patients with ULMCD are limited to the Left Main Stenting trial and the LM subset of the SYNTAX trial

Study Flow Diagram ACS + LM stenosis (n=2783) PCI (n=514) Analysis based on 43 018 patients ACS + LM stenosis (n=2783) Excluded: Hx of CABG (n=921) Both CABG + PCI during hospital° (n=43) Missing data (n=20) Study group: ACS +unprotected LM (n=1799) PCI (n=514) CABG (n=612) Conservative treatment (n=673)

ULMCD Revascularization in ACS Temporal Trends in Severity of ACS Temporal Trends in Type of Revascularization

In-Hospital Mortality Cardiac arrest or cardiogenic shock STEMI ALL 34 % 11 % 7.7 % 14% at 6 months

Cumulative Death Rate by Revascularization Group as a Time-Varying Covariate CABG Conservative PCI 45 90 135 180 0.20 0.10 Cumulative all death rate Days since admission

Cox Regression Model for Death Hospital stay  early hazard of revascularization PCI vs. Conservative: HR 2.60 (95% CI 1.62-4.18) CABG vs. Conservative: HR 1.26 (95% CI 0.72-2.22) From Discharge to 6 months  improved survival of revascularization so that if a patient underwent CABG on day 4 after admission they were counted as not having revascularization performed on days 0 to 3, and as having had CABG surgery from day 4 onwards. PCI vs. Conservative: HR 0.45 (95% CI 0.23-0.85) CABG vs. Conservative: HR 0.11 (95% CI 0.04-0.28)

Cumulative Rate of Stroke by Revascularization Group as a Time-Varying Covariate 45 90 135 180 Days since admission Cumulative all stroke rate CABG Conservative PCI 0.08 0.04

Conclusion ULMCD in ACS is a rare situation (4%) ULMCD in ACS is a serious situation (in-hospital mortality of 7.7%) PCI has become the most common strategy of revascularization (is preferred in emergent/serious cases) CABG is associated with good survival (is performed in lower-risk patients) The 2 modes of revascularization appear complementary No aspirin? Would a bleeding occur, how would you manage?

Available now online from European Heart Journal Authors: Gilles Montalescot, David Brieger, Kim A. Eagle, Frederick A. Anderson Jr, Gordon FitzGerald, Michael S. Lee, Ph Gabriel Steg, A´ lvaro Avezum, Shaun G. Goodman, and Joel M. Gore for the GRACE Investigators http://eurheartj.oxfordjournals.org/cgi/content/full/ehp353